Medical Condition News

RSS

Scientists develop innovative device to efficiently identify CTCs in blood

Circulating tumor cells, which play a crucial role in cancer metastasis, have been known to science for more than 100 years, and researchers have long endeavored to track and capture them.

8 Mar 2011

Two studies show how laminin plays a central role in breast cancer development

Laminin, long thought to be only a structural support protein in the microenvironment of breast and other epithelial tissues, is "famous" for its cross-like shape.

8 Mar 2011

hUCBs and MenSCs transplant may offer future therapeutic benefit for AD, stroke, ALS

Transplanting stem cells derived from umbilical cord blood cells and menstrual blood cells may offer future therapeutic benefit for those suffering from stroke, Alzheimer's disease, and amyotrophic lateral sclerosis, says a team of neuroscience researchers from the University of South Florida's Department of Neurosurgery and Brain Repair and collaborators from three private-sector research groups, Saneron CCEL Therapeutics, Inc., Tampa, FL, Cryo-Cell International, Inc., Oldsmar, FL, and Cryopraxis, Cell Praxis, BioRio, Rio de Janeiro, Brazil.

8 Mar 2011

New discovery can provide insight into lung cancer

A discovery at University of Colorado Cancer Center shows testing lung cancer on a molecular level can produce new insights into this deadly disease.

8 Mar 2011

New study reveals role of INK4, ARF proteins in Burkitt's lymphoma

Burkitt's lymphoma is one of the most aggressive tumors affecting humans. Multiple alterations in genes that regulate cell proliferation rate explain its aggressive behavior.

8 Mar 2011

FDA clears Breathe BT-V2S ventilator for COPD disease management

Breathe Technologies, Inc., a manufacturer of innovative technology solutions for people with respiratory conditions, including chronic obstructive pulmonary disease, announced today that it has received FDA clearance for use of the Breathe Technologies BT-V2S ventilator in the home setting.

8 Mar 2011

Alliqua completes transdermal pain patch initial in vitro study for treatment of PHN

Alliqua, Inc., an advanced biomedical products company focused on the development and manufacturing of proprietary drug delivery and liver health technologies, announced today the successful completion of its initial in vitro permeation study for its transdermal pain patch project.

8 Mar 2011

AstraZeneca grants $2.5 million to 14 U.S.-based organizations to improve cardiovascular health

The AstraZeneca HealthCare Foundation today announced grants totaling more than $2.5 million to 14 U.S.-based nonprofit organizations from Maine to California dedicated to improving cardiovascular health in local communities.

8 Mar 2011

New Lupus drug marching towards approval

A new drug for lupus from the Human Genome Sciences Inc is all set to get clearance in the US this week. If all goes through, this drug will offer patients the first approved treatment option in a half-century, setting the manufacturer up for huge sales.

7 Mar 2011

Prevalence of eating disorders higher than previously thought

A new study shows that many American adolescents suffer from an eating disorder and struggle with related psychiatric disorders, including suicidal tendencies. The researchers write, “The prevalence of these disorders is higher than previously expected in this age range, and the patterns of [co-existing illnesses], role impairment and suicidality indicate that eating disorders represent a major public health concern.” Led by Sonja A. Swanson, of the National Institute of Mental Health, the research team reported the findings online March 7 in the Archives of General Psychiatry.

7 Mar 2011

Prevalence of bipolar disorder

Bipolar disorder is a psychiatric disorder that swings between depression and mania. It strikes early and can cause lifelong disability. Reports show that it is chronically undertreated in many low-income countries.

7 Mar 2011

Down’s syndrome could be detected in mother’s blood test

European researchers have devised a blood test that could help pregnant women avoid the invasive procedures now used to diagnose Down syndrome prenatally and make the diagnosis with 100% accuracy. The study report was published this Sunday in Nature Medicine.

7 Mar 2011

Article sheds new light on neural mechanisms for flashbacks

Flashbacks are an elusive phenomenon, but an article published in the current issue of Psychotherapy and Psychosomatics sheds some new light on potential mechanisms in an healthy man with an history of near drawing.

7 Mar 2011

Hadasit, Yissum license innovative regenerative membrane implant to RegeneCure

Yissum Research Development Company Ltd., the technology transfer company of the Hebrew University of Jerusalem, and Hadasit Medical Research Services & Development Ltd., the technology transfer company of the Hadassah University Medical Center, today announced that they have licensed innovative regenerative membrane implant technology to RegeneCure, which will further develop and commercialize the technology for bone tissue engineering for applications in trauma, spine, and reconstructive cranial and facial orthopedics.

7 Mar 2011

Solasia, ZIOPHARM enter license and collaboration agreement for darinaparsin product

ZIOPHARM Oncology, Inc., an oncology small molecule and synthetic biology drug development company, and Solasia Pharma K.K., a developer of Western oncology pharmaceuticals in-licensed for commercialization in Asian markets, announced today that they have entered into a license and collaboration agreement to develop and commercialize ZIOPHARM's darinaparsin product and related organic arsenic molecules in specified Pan-Asian/Pacific territories.

7 Mar 2011

New research: Lung cancer rates have doubled for women over 60 since mid 1970s

Lung cancer rates have doubled for women over 60 since the mid 1970s according to new Cancer Research UK figures released today ahead of No Smoking Day this Wednesday.

7 Mar 2011

Inovio initiates VGX-3100 Phase II trial in patients with cervical cancer

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it is initiating a Phase II clinical trial for its VGX-3100 DNA vaccine for cervical dysplasia and cancer caused by human papillomavirus.

7 Mar 2011

Scientists develop unique device to measure short-lived radioactive thoron

"Many people are now saying: 'Is it really that easy? Then why didn't anyone think of it a long time ago?' But you have to have the right idea at the right time," says Annette Röttger, physicist at the Physikalisch-Technische Bundesanstalt, in a pleased way. Annette Röttger and her scientific team managed to do something that was previously thought to be impossible: they developed a primary standard for the measurement of short-lived radioactive thoron.

7 Mar 2011

Sectra receives strategic order from Trillium for MicroDose Mammography system

The women of Canada will soon benefit from low-dose mammography. Trillium Radiology Associates, which operates private diagnostic imaging facilities in Toronto and Mississauga, has invested in four digital mammography systems from the IT and medical technology company Sectra. The system was sold by Xtron Imaging Inc., Sectra's new distribution partner for Canada.

7 Mar 2011

USPTO grants patent to Symphogen's Sym004 to treat solid tumors

Symphogen, a private biopharmaceutical company developing superior antibody therapeutics, said the company had been granted a US patent for Sym004 as well as other antibody compositions containing at least two distinct anti-EGFR antibodies having certain binding characteristics.

7 Mar 2011